GlucoTrack, Inc.
General ticker "GCTK" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $21.8M (TTM average)
GlucoTrack, Inc. does not follow the US Stock Market performance with the rate: -9.5%.
Estimated limits based on current volatility of 6.5%: low 5.78$, high 6.58$
Factors to consider:
- Total employees count: 6 (+100.0%) as of 2023
- Top business risk factors: Liquidity and credit risks, Operating losses and lack of profitability, Market competition, Strategic risks and growth management, Labor/talent shortage/retention
- Current price 89.0% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [154.99$, 785.88$]
- 2024-12-30 to 2025-12-30 estimated range: [54.48$, 280.33$]
Financial Metrics affecting the GCTK estimates:
- Negative: with PPE of -2.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.29 <= 0.33
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 0 <= 5.52
- Negative: Industry operating profit margin (median), % of -7.65 <= 2.97
- Negative: Industry inventory ratio change (median), % of 0.65 > 0.28
- Negative: Shareholder equity ratio, % of 65.18 > 63.39
Short-term GCTK quotes
Long-term GCTK plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.04MM | $4.43MM | $7.10MM |
| Operating Income | $-4.04MM | $-4.43MM | $-7.10MM |
| Non-Operating Income | $-0.03MM | $-0.00MM | $0.01MM |
| R&D Expense | $1.81MM | $1.97MM | $4.70MM |
| Income(Loss) | $-4.07MM | $-4.43MM | $-7.10MM |
| Profit(Loss)* | $-4.07MM | $-4.43MM | $-7.10MM |
| Stockholders Equity | $5.16MM | $1.23MM | $3.20MM |
| Assets | $6.26MM | $2.44MM | $4.91MM |
| Operating Cash Flow | $-3.77MM | $-3.73MM | $-6.56MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $-0.00MM | $-0.05MM | $8.73MM |
| Earnings Per Share** | $-26.41 | $-28.80 | $-38.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.